Product Information
PRIMIDONE 50 MG TABLET is a generic product labeled by Carnegie Pharmaceuticals LLC, priced at $0.0914 per EA under NDC 80005011711. Its NADAC has been published 103 times since Oct 16, 2024.
FDA first approved this application on Jan 23, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Carnegie Pharmaceuticals LLCNDC
80005011711
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRIMIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA218366FDA Approved
1/23/2024
TE Code
AB
On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for PRIMIDONE 50 MG TABLET has been published 103 times since Oct 16, 2024, and over the history we have for it it has declined 32.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0914 per EA |
|---|---|
| All-time high | $0.1350 (Oct 16, 2024) |
| All-time low | $0.0914 (Sep 23, 2026) |
| 52-week high | $0.1080 |
| 52-week low | $0.0914 |
| Median price | $0.1060 |
| Average price | $0.1066 |
| Largest weekly change | -22.9% (Nov 20, 2024) |
| Weeks tracked | 103 |
| Tracking since | Oct 16, 2024 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Carnegie Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Primidone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRIMIDONE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRIMIDONE 50 MG TABLET, manufactured by Carnegie Pharmaceuticals LLC, is $0.0914 per EA (NDC 80005011711), effective Sep 30, 2026.
How has the price of PRIMIDONE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRIMIDONE 50 MG TABLET has declined 32.3%. It has been tracked across 103 weekly CMS publications since Oct 16, 2024.
What are the highest and lowest recorded NADAC prices for PRIMIDONE 50 MG TABLET?
Since Oct 16, 2024, the NADAC for PRIMIDONE 50 MG TABLET has ranged from a low of $0.0914 (Sep 23, 2026) to a high of $0.1350 (Oct 16, 2024), with a median of $0.1060 per EA.
Are there cheaper alternatives to PRIMIDONE 50 MG TABLET?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRIMIDONE 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PRIMIDONE 50 MG TABLET?
PRIMIDONE 50 MG TABLET (NDC 80005011711) is labeled by Carnegie Pharmaceuticals LLC, and CMS classifies it as a generic product.